A Study to Test How Well Healthy People Tolerate Spesolimab When Given in 2 Different Ways
Status:
COMPLETED
Trial end date:
2025-02-04
Target enrollment:
Participant gender:
Summary
The main objectives of this trial is to investigate the safety and tolerability of a single dose of spesolimab administered in 2 different ways in healthy subjects.